Vespula pensylvanica isolate Volc-1 chromosome 6, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025341.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
beta-1,4-glucuronyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1-like isoform X2
beta-1,4-glucuronyltransferase 1-like isoform X1
uncharacterized LOC122629782, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC122629782, transcript variant X1
uncharacterized protein LOC122629782 isoform X1
uncharacterized protein LOC122629782 isoform X2
protein tumorous imaginal discs, mitochondrial, transcript variant X1
protein tumorous imaginal discs, mitochondrial isoform X1
protein tumorous imaginal discs, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial, transcript variant X3
protein tumorous imaginal discs, mitochondrial isoform X2
sphingomyelin synthase-related 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
sphingomyelin synthase-related 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein jim lovell, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein jim lovell, transcript variant X4
protein jim lovell, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein jim lovell, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein jim lovell, transcript variant X5
programmed cell death protein 6, transcript variant X3
programmed cell death protein 6, transcript variant X1
programmed cell death protein 6, transcript variant X2
programmed cell death protein 6, transcript variant X4
programmed cell death protein 6 isoform X3
programmed cell death protein 6 isoform X1
programmed cell death protein 6 isoform X4
programmed cell death protein 6 isoform X2
dolichyl-phosphate beta-glucosyltransferase
integrin-linked protein kinase homolog pat-4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
muscle M-line assembly protein unc-89-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122630111, transcript variant X3
uncharacterized LOC122630111, transcript variant X1
uncharacterized LOC122630111, transcript variant X4
uncharacterized LOC122630111, transcript variant X2
uncharacterized LOC122630111, transcript variant X5
uncharacterized protein LOC122630111 isoform X1
uncharacterized protein LOC122630111 isoform X2
uncharacterized protein LOC122630111 isoform X3
uncharacterized LOC122630112, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122630112, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122630112, transcript variant X3
uncharacterized protein LOC122630112 isoform X1
uncharacterized protein LOC122630112 isoform X2
lethal(3)malignant brain tumor-like protein 3, transcript variant X1
lethal(3)malignant brain tumor-like protein 3, transcript variant X6
lethal(3)malignant brain tumor-like protein 3, transcript variant X5
lethal(3)malignant brain tumor-like protein 3, transcript variant X4
lethal(3)malignant brain tumor-like protein 3, transcript variant X3
lethal(3)malignant brain tumor-like protein 3, transcript variant X2
lethal(3)malignant brain tumor-like protein 3 isoform X1
lethal(3)malignant brain tumor-like protein 3 isoform X2
lethal(3)malignant brain tumor-like protein 3 isoform X3
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X4
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X2
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X3
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like, transcript variant X1
protein-L-isoaspartate O-methyltransferase domain-containing protein 1-like
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X2
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X3
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X1
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X4
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X1
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X2
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase-like, transcript variant X5
electron transfer flavoprotein beta subunit lysine methyltransferase-like isoform X3
nuclear receptor-binding protein homolog, transcript variant X1
nuclear receptor-binding protein homolog, transcript variant X2
nuclear receptor-binding protein homolog isoform X1
nuclear receptor-binding protein homolog isoform X2
phospholipase A2 group XV-like, transcript variant X2
phospholipase A2 group XV-like, transcript variant X1
phospholipase A2 group XV-like isoform X2
phospholipase A2 group XV-like isoform X1
secretion-regulating guanine nucleotide exchange factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122630050, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122630050, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC122630050 isoform X1
uncharacterized protein LOC122630050 isoform X2
elongation factor Ts, mitochondrial, transcript variant X1
elongation factor Ts, mitochondrial, transcript variant X2
elongation factor Ts, mitochondrial, transcript variant X3
elongation factor Ts, mitochondrial, transcript variant X4
elongation factor Ts, mitochondrial isoform X1
elongation factor Ts, mitochondrial isoform X2
elongation factor Ts, mitochondrial isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
class E basic helix-loop-helix protein 23
uncharacterized LOC122630037, transcript variant X3
uncharacterized LOC122630037, transcript variant X2
uncharacterized protein LOC122630037 isoform X2
uncharacterized LOC122630037, transcript variant X1
uncharacterized protein LOC122630037 isoform X1
uncharacterized protein LOC122630037 isoform X3
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X1
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X1
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X2
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial, transcript variant X3
probable hydroxyacid-oxoacid transhydrogenase, mitochondrial isoform X2
glyceraldehyde-3-phosphate dehydrogenase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 172 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glyceraldehyde-3-phosphate dehydrogenase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 101 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glyceraldehyde-3-phosphate dehydrogenase 1-like isoform X1
glyceraldehyde-3-phosphate dehydrogenase-like isoform X2
glyceraldehyde-3-phosphate dehydrogenase 2-like
ralBP1-associated Eps domain-containing protein 1
protein lethal(2)essential for life-like
E3 ubiquitin-protein ligase XIAP-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
E3 ubiquitin-protein ligase XIAP-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
E3 ubiquitin-protein ligase XIAP-like isoform X1
baculoviral IAP repeat-containing protein 8-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cell division cycle protein 23 homolog, transcript variant X1
cell division cycle protein 23 homolog, transcript variant X2
cell division cycle protein 23 homolog isoform X3
cell division cycle protein 23 homolog isoform X2
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog, transcript variant X9
cell division cycle protein 23 homolog isoform X6
cell division cycle protein 23 homolog, transcript variant X6
cell division cycle protein 23 homolog, transcript variant X7
cell division cycle protein 23 homolog, transcript variant X8
neither inactivation nor afterpotential protein C, transcript variant X3
neither inactivation nor afterpotential protein C, transcript variant X1
neither inactivation nor afterpotential protein C, transcript variant X2
neither inactivation nor afterpotential protein C isoform X2
neither inactivation nor afterpotential protein C isoform X1
neither inactivation nor afterpotential protein C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
neither inactivation nor afterpotential protein C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
neither inactivation nor afterpotential protein C isoform X3
neither inactivation nor afterpotential protein C, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
neither inactivation nor afterpotential protein C isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein Wnt-6-like, transcript variant X2
protein Wnt-6-like, transcript variant X1
protein Wnt-6-like, transcript variant X3
PC4 and SFRS1-interacting protein, transcript variant X1
PC4 and SFRS1-interacting protein, transcript variant X2
PC4 and SFRS1-interacting protein isoform X2
PC4 and SFRS1-interacting protein isoform X1
bone morphogenetic protein receptor type-2, transcript variant X4
bone morphogenetic protein receptor type-2, transcript variant X3
bone morphogenetic protein receptor type-2, transcript variant X1
bone morphogenetic protein receptor type-2 isoform X3
bone morphogenetic protein receptor type-2, transcript variant X2
bone morphogenetic protein receptor type-2 isoform X1
bone morphogenetic protein receptor type-2 isoform X2
43 kDa receptor-associated protein of the synapse homolog, transcript variant X3
43 kDa receptor-associated protein of the synapse homolog, transcript variant X1
43 kDa receptor-associated protein of the synapse homolog, transcript variant X2
43 kDa receptor-associated protein of the synapse homolog isoform X3
43 kDa receptor-associated protein of the synapse homolog isoform X2
43 kDa receptor-associated protein of the synapse homolog isoform X1
transcription factor SUM-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor SUM-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcription factor SUM-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
afadin- and alpha-actinin-binding protein-like, transcript variant X3
afadin- and alpha-actinin-binding protein-like, transcript variant X2
afadin- and alpha-actinin-binding protein-like, transcript variant X1
afadin- and alpha-actinin-binding protein-like isoform X1
afadin- and alpha-actinin-binding protein-like isoform X2
uncharacterized LOC122629925, transcript variant X2
uncharacterized LOC122629925, transcript variant X1
uncharacterized LOC122629853, transcript variant X1
uncharacterized LOC122629853, transcript variant X2
uncharacterized protein LOC122629853 isoform X2
uncharacterized protein LOC122629853 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
dynein axonemal intermediate chain 7 homolog, transcript variant X2
dynein axonemal intermediate chain 7 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein axonemal intermediate chain 7 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vanin-like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
vanin-like protein 1, transcript variant X1
vanin-like protein 1, transcript variant X3
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X1
cytochrome b-c1 complex subunit Rieske, mitochondrial-like, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X1
cytochrome b-c1 complex subunit Rieske, mitochondrial-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 11-like
rho guanine nucleotide exchange factor 7, transcript variant X2
rho guanine nucleotide exchange factor 7
rho guanine nucleotide exchange factor 7, transcript variant X1
uncharacterized LOC122629931, transcript variant X2
uncharacterized LOC122629931, transcript variant X1
uncharacterized protein LOC122629931 isoform X2
uncharacterized protein LOC122629931 isoform X1
macro domain-containing protein CT2219-like, transcript variant X2
macro domain-containing protein CT2219-like, transcript variant X1
macro domain-containing protein CT2219-like isoform X2
macro domain-containing protein CT2219-like isoform X1
macro domain-containing protein CT2219-like, transcript variant X3
macro domain-containing protein CT2219-like isoform X3
serine/threonine-protein kinase MARK2-like, transcript variant X18
serine/threonine-protein kinase MARK2-like, transcript variant X19
serine/threonine-protein kinase MARK2-like, transcript variant X1
serine/threonine-protein kinase MARK2-like, transcript variant X9
serine/threonine-protein kinase MARK2-like, transcript variant X6
serine/threonine-protein kinase MARK2-like, transcript variant X16
serine/threonine-protein kinase MARK2-like, transcript variant X17
serine/threonine-protein kinase MARK2-like, transcript variant X12
serine/threonine-protein kinase MARK2-like, transcript variant X13
serine/threonine-protein kinase MARK2-like, transcript variant X8
serine/threonine-protein kinase MARK2-like, transcript variant X7
serine/threonine-protein kinase MARK2-like, transcript variant X11
serine/threonine-protein kinase MARK2-like, transcript variant X5
serine/threonine-protein kinase MARK2-like, transcript variant X14
serine/threonine-protein kinase MARK2-like, transcript variant X15
serine/threonine-protein kinase MARK2-like, transcript variant X10
serine/threonine-protein kinase MARK2-like, transcript variant X2
serine/threonine-protein kinase MARK2-like, transcript variant X4
serine/threonine-protein kinase MARK2-like, transcript variant X3
serine/threonine-protein kinase MARK2-like isoform X1
serine/threonine-protein kinase MARK2-like isoform X9
serine/threonine-protein kinase MARK2-like isoform X6
serine/threonine-protein kinase MARK2-like isoform X10
serine/threonine-protein kinase MARK2-like isoform X2
serine/threonine-protein kinase MARK2-like isoform X11
serine/threonine-protein kinase MARK2-like isoform X12
serine/threonine-protein kinase MARK2-like isoform X5
serine/threonine-protein kinase MARK2-like isoform X3
serine/threonine-protein kinase MARK2-like isoform X4
serine/threonine-protein kinase MARK2-like isoform X7
serine/threonine-protein kinase MARK2-like isoform X8
serine/threonine-protein kinase MARK2-like isoform X13
serine/threonine-protein kinase MARK2-like isoform X15
serine/threonine-protein kinase MARK2-like isoform X14
serine/threonine-protein kinase MARK2-like isoform X16
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
elongator complex protein 1, transcript variant X1
elongator complex protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
vacuolar protein sorting-associated protein 26C
protein mono-ADP-ribosyltransferase PARP16, transcript variant X2
protein mono-ADP-ribosyltransferase PARP16, transcript variant X1
protein mono-ADP-ribosyltransferase PARP16
protein-serine O-palmitoleoyltransferase porcupine, transcript variant X3
protein-serine O-palmitoleoyltransferase porcupine, transcript variant X1
protein-serine O-palmitoleoyltransferase porcupine, transcript variant X2
protein-serine O-palmitoleoyltransferase porcupine
uncharacterized LOC122630263, transcript variant X1
uncharacterized LOC122630263, transcript variant X2
uncharacterized protein LOC122630263 isoform X1
uncharacterized protein LOC122630263 isoform X2
uncharacterized LOC122630263, transcript variant X3
uncharacterized protein LOC122630263 isoform X3
mitochondrial proton/calcium exchanger protein
vacuolar protein sorting-associated protein 13B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13B isoform X1
vacuolar protein sorting-associated protein 13B isoform X2
vacuolar protein sorting-associated protein 13B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
vacuolar protein sorting-associated protein 13B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
alpha-tocopherol transfer protein-like, transcript variant X3
alpha-tocopherol transfer protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
alpha-tocopherol transfer protein-like, transcript variant X1
alpha-tocopherol transfer protein-like isoform X1
alpha-tocopherol transfer protein-like isoform X2
rho-related BTB domain-containing protein 1, transcript variant X2
rho-related BTB domain-containing protein 1, transcript variant X3
rho-related BTB domain-containing protein 1, transcript variant X4
rho-related BTB domain-containing protein 1, transcript variant X6
rho-related BTB domain-containing protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
rho-related BTB domain-containing protein 1, transcript variant X7
rho-related BTB domain-containing protein 1, transcript variant X5
rho-related BTB domain-containing protein 1, transcript variant X1
rho-related BTB domain-containing protein 1 isoform X1
rho-related BTB domain-containing protein 1 isoform X2
rho-related BTB domain-containing protein 1 isoform X3
H/ACA ribonucleoprotein complex subunit 2-like protein, transcript variant X2
H/ACA ribonucleoprotein complex subunit 2-like protein, transcript variant X3
H/ACA ribonucleoprotein complex subunit 2-like protein, transcript variant X1
H/ACA ribonucleoprotein complex subunit 2-like protein
poly [ADP-ribose] polymerase tankyrase, transcript variant X1
poly [ADP-ribose] polymerase tankyrase, transcript variant X2
poly [ADP-ribose] polymerase tankyrase isoform X1
poly [ADP-ribose] polymerase tankyrase isoform X2
protein phosphatase 1 regulatory subunit 3B, transcript variant X3
protein phosphatase 1 regulatory subunit 3B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 3B, transcript variant X1
protein phosphatase 1 regulatory subunit 3B, transcript variant X2
protein phosphatase 1 regulatory subunit 3B-A isoform X1
protein phosphatase 1 regulatory subunit 3B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
interleukin enhancer-binding factor 2 homolog
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7, transcript variant X2
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7, transcript variant X1
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 isoform X1
bifunctional peptidase and (3S)-lysyl hydroxylase Jmjd7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel trpm, transcript variant X1
transient receptor potential cation channel trpm, transcript variant X4
transient receptor potential cation channel trpm, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X2
transient receptor potential cation channel trpm, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transient receptor potential cation channel trpm, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transient receptor potential cation channel trpm isoform X5
transient receptor potential cation channel trpm isoform X2
transient receptor potential cation channel trpm isoform X6
transient receptor potential cation channel trpm isoform X3
transient receptor potential cation channel trpm isoform X4
transient receptor potential cation channel trpm isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
leucine-rich repeat and calponin homology domain-containing protein-like, transcript variant X2
leucine-rich repeat and calponin homology domain-containing protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
leucine-rich repeat and calponin homology domain-containing protein-like isoform X2
leucine-rich repeat and calponin homology domain-containing protein-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
integrin beta-PS-like, transcript variant X1
integrin beta-PS-like, transcript variant X2
mothers against decapentaplegic homolog 3, transcript variant X1
mothers against decapentaplegic homolog 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
mothers against decapentaplegic homolog 3
serine/arginine repetitive matrix protein 5, transcript variant X1
serine/arginine repetitive matrix protein 5, transcript variant X2
serine/arginine repetitive matrix protein 5 isoform X1
serine/arginine repetitive matrix protein 5 isoform X2
putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
probable U3 small nucleolar RNA-associated protein 11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122629869, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122629869, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122629869 isoform X2
uncharacterized protein LOC122629869 isoform X1
skeletal aspartic acid-rich protein 2-like, transcript variant X1
skeletal aspartic acid-rich protein 2-like, transcript variant X2
skeletal aspartic acid-rich protein 2-like
probable serine/threonine-protein kinase cdc7
uncharacterized LOC122629837, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122629837, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
glutamate receptor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor 3-like, transcript variant X1
glutamate receptor U1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor U1-like, transcript variant X1
glutamate receptor U1-like, transcript variant X3
glutamate receptor ionotropic, kainate 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122629960, transcript variant X1
uncharacterized LOC122629960, transcript variant X2
uncharacterized LOC122629960, transcript variant X3
uncharacterized protein LOC122629960 isoform X1
uncharacterized protein LOC122629960 isoform X2
uncharacterized protein LOC122629960 isoform X3
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
glutamate receptor ionotropic, delta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, delta-2-like, transcript variant X2
glutamate receptor ionotropic, delta-2-like, transcript variant X3
glutamate receptor ionotropic, delta-2-like, transcript variant X1
glutamate receptor ionotropic, delta-2-like isoform X3
glutamate receptor ionotropic, delta-2-like isoform X1
glutamate receptor ionotropic, delta-2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122629889, transcript variant X2
uncharacterized LOC122629889, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC122629889 isoform X1
uncharacterized protein LOC122629889 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
28S ribosomal protein S29, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized protein C9orf85 homolog, transcript variant X2
uncharacterized protein C9orf85 homolog, transcript variant X3
uncharacterized protein C9orf85 homolog, transcript variant X1
uncharacterized protein C9orf85 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized protein C9orf85 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized protein C9orf85 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein C9orf85 homolog isoform X2
uncharacterized protein C9orf85 homolog isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122630290, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122630290, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC122630290, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122630290, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC122630290 isoform X1
uncharacterized protein LOC122630290 isoform X2
uncharacterized LOC122630290, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC122630290 isoform X3
myb-like protein Q, transcript variant X1
myb-like protein Q, transcript variant X2
uncharacterized LOC122630007, transcript variant X2
uncharacterized LOC122630007, transcript variant X1
muscle segmentation homeobox-like, transcript variant X2
muscle segmentation homeobox-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
synaptonemal complex protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
synaptonemal complex protein 1-like, transcript variant X1
synaptonemal complex protein 1-like, transcript variant X3
synaptonemal complex protein 1-like isoform X1
uncharacterized protein LOC122629790 isoform X2
nucleoplasmin-like protein, transcript variant X1
nucleoplasmin-like protein, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adenylate cyclase type 10-like
ELKS/Rab6-interacting/CAST family member 1-like
ELKS/Rab6-interacting/CAST family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ELKS/Rab6-interacting/CAST family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ELKS/Rab6-interacting/CAST family member 1 isoform X2
ELKS/Rab6-interacting/CAST family member 1 isoform X1
late cornified envelope-like proline-rich protein 1
putative mediator of RNA polymerase II transcription subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
neuralized-like protein 2, transcript variant X2
neuralized-like protein 2, transcript variant X1
neuronal acetylcholine receptor subunit alpha-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
neuronal acetylcholine receptor subunit beta-3-like, transcript variant X2
neuronal acetylcholine receptor subunit beta-3-like, transcript variant X1
neuronal acetylcholine receptor subunit beta-3-like isoform X1
neuronal acetylcholine receptor subunit beta-3-like isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
GATOR complex protein NPRL3, transcript variant X1
GATOR complex protein NPRL3, transcript variant X2
pleiotropic regulator 1, transcript variant X2
pleiotropic regulator 1, transcript variant X1
pleiotropic regulator 1, transcript variant X3
pleckstrin homology domain-containing family J member 1-like
uncharacterized LOC122629948, transcript variant X1
uncharacterized LOC122629948, transcript variant X2
uncharacterized protein LOC122629948 isoform X1
uncharacterized protein LOC122629948 isoform X2
very low-density lipoprotein receptor-like, transcript variant X1
very low-density lipoprotein receptor-like, transcript variant X2
very low-density lipoprotein receptor-like, transcript variant X4
very low-density lipoprotein receptor-like, transcript variant X5
very low-density lipoprotein receptor-like, transcript variant X3
very low-density lipoprotein receptor-like isoform X5
very low-density lipoprotein receptor-like isoform X3
very low-density lipoprotein receptor-like isoform X4
very low-density lipoprotein receptor-like isoform X2
very low-density lipoprotein receptor-like isoform X1
WD repeat domain-containing protein 83, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
WD repeat domain-containing protein 83, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
WD repeat domain-containing protein 83, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein PFB0145c-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC4-like, transcript variant X1
protein O-mannosyl-transferase TMTC4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC4-like isoform X1
protein O-mannosyl-transferase TMTC4-like isoform X2
snRNA-activating protein complex subunit 3
paired box pox-meso protein-like, transcript variant X2
paired box pox-meso protein-like isoform X2
paired box pox-meso protein-like, transcript variant X1
paired box pox-meso protein-like isoform X1
ATP synthase-coupling factor 6, mitochondrial-like
DNA polymerase epsilon catalytic subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
adenylosuccinate synthetase, transcript variant X1
adenylosuccinate synthetase, transcript variant X2
WD repeat-containing protein 37, transcript variant X1
WD repeat-containing protein 37, transcript variant X2
WD repeat-containing protein 37 isoform X1
WD repeat-containing protein 37 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
katanin p60 ATPase-containing subunit A-like 2
uncharacterized LOC122630214, transcript variant X1
uncharacterized LOC122630214, transcript variant X2
omega-amidase NIT2, transcript variant X2
omega-amidase NIT2, transcript variant X1
uncharacterized LOC122630205, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC122630205, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122630205, transcript variant X1
uncharacterized LOC122630205, transcript variant X5
G-patch domain and KOW motifs-containing protein-like
uncharacterized LOC122630205, transcript variant X3
uncharacterized protein LOC122630205 isoform X1
uncharacterized protein LOC122630205 isoform X2
SWI5-dependent HO expression protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein basonuclin-2-like, transcript variant X3
zinc finger protein basonuclin-2-like, transcript variant X2
zinc finger protein basonuclin-2-like, transcript variant X1
zinc finger protein basonuclin-2-like isoform X1
zinc finger protein basonuclin-2-like isoform X2
cilia- and flagella-associated protein 43-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 2% coverage of the annotated genomic feature by RNAseq alignments
Krueppel-like factor luna, transcript variant X2
Krueppel-like factor luna, transcript variant X1
Krueppel-like factor luna, transcript variant X5
Krueppel-like factor luna, transcript variant X4
Krueppel-like factor luna, transcript variant X3
gonadotropin-releasing hormone II receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gonadotropin-releasing hormone II receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gonadotropin-releasing hormone receptor isoform X2
gonadotropin-releasing hormone II receptor isoform X1
histone H1, gonadal-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histone H1, gonadal-like, transcript variant X3
histone H1, gonadal-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X1
zwei Ig domain protein zig-8-like isoform X2
zwei Ig domain protein zig-8-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC122630271 isoform X1
uncharacterized LOC122629993, transcript variant X3
uncharacterized LOC122629993, transcript variant X2
uncharacterized LOC122629993, transcript variant X5
uncharacterized LOC122629993, transcript variant X8
uncharacterized LOC122629993, transcript variant X4
uncharacterized LOC122629993, transcript variant X1
uncharacterized LOC122629993, transcript variant X7
uncharacterized LOC122629993, transcript variant X6
uncharacterized protein LOC122629993 isoform X2
uncharacterized protein LOC122629993 isoform X4
uncharacterized protein LOC122629993 isoform X3
uncharacterized protein LOC122629993 isoform X1
uncharacterized protein LOC122629993 isoform X5
uncharacterized protein LOC122629993 isoform X6
uncharacterized protein LOC122629993 isoform X7
uncharacterized LOC122629993, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized protein LOC122629993 isoform X8
serine/threonine-protein kinase ULK3, transcript variant X1
serine/threonine-protein kinase ULK3, transcript variant X2
serine/threonine-protein kinase ULK3 isoform X1
serine/threonine-protein kinase ULK3 isoform X2
E3 ubiquitin-protein ligase ariadne-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
E3 ubiquitin-protein ligase ariadne-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
E3 ubiquitin-protein ligase ariadne-1, transcript variant X5
E3 ubiquitin-protein ligase ariadne-1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
E3 ubiquitin-protein ligase ariadne-1, transcript variant X2
E3 ubiquitin-protein ligase ariadne-1 isoform X2
E3 ubiquitin-protein ligase ariadne-1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B, transcript variant X1
synaptic vesicle glycoprotein 2B, transcript variant X2
synaptic vesicle glycoprotein 2B, transcript variant X3
synaptic vesicle glycoprotein 2B, transcript variant X5
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
synaptic vesicle glycoprotein 2B, transcript variant X4
dual specificity mitogen-activated protein kinase kinase dSOR1
sodium/potassium-transporting ATPase subunit alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
BAG domain-containing protein Samui-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
BAG domain-containing protein Samui-like isoform X1
BAG domain-containing protein Samui-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
BAG domain-containing protein Samui-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
BAG domain-containing protein Samui-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
BAG domain-containing protein Samui-like isoform X2
abscission/NoCut checkpoint regulator, transcript variant X3
abscission/NoCut checkpoint regulator, transcript variant X1
abscission/NoCut checkpoint regulator, transcript variant X4
abscission/NoCut checkpoint regulator, transcript variant X2
abscission/NoCut checkpoint regulator isoform X1
abscission/NoCut checkpoint regulator isoform X2
SUN domain-containing protein 1-like, transcript variant X2
SUN domain-containing protein 1-like, transcript variant X1
SUN domain-containing protein 3-like isoform X2
SUN domain-containing protein 1-like isoform X1
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X1
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X2
sodium-dependent nutrient amino acid transporter 1-like isoform X1
sodium-dependent nutrient amino acid transporter 1-like isoform X2
sodium-dependent nutrient amino acid transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sodium-dependent nutrient amino acid transporter 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122629919, transcript variant X6
uncharacterized LOC122629919, transcript variant X7
uncharacterized LOC122629919, transcript variant X2
uncharacterized LOC122629919, transcript variant X8
uncharacterized LOC122629919, transcript variant X1
uncharacterized LOC122629919, transcript variant X3
uncharacterized LOC122629919, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122629919, transcript variant X4
uncharacterized LOC122629919, transcript variant X5
uncharacterized protein LOC122629919 isoform X1
uncharacterized protein LOC122629919 isoform X2
uncharacterized protein LOC122629919 isoform X3
uncharacterized protein LOC122629919 isoform X5
uncharacterized LOC122629919, transcript variant X9
uncharacterized protein LOC122629919 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
intraflagellar transport protein 46 homolog, transcript variant X1
intraflagellar transport protein 46 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
intraflagellar transport protein 46 homolog isoform X1
intraflagellar transport protein 46 homolog isoform X3
intraflagellar transport protein 46 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
intraflagellar transport protein 46 homolog isoform X2
uncharacterized LOC122630240, transcript variant X4
uncharacterized LOC122630240, transcript variant X5
uncharacterized LOC122630240, transcript variant X3
uncharacterized LOC122630240, transcript variant X1
uncharacterized LOC122630240, transcript variant X2
uncharacterized LOC122630240, transcript variant X6
diphthine methyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
diphthine methyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
uncharacterized LOC122630237, transcript variant X2
uncharacterized LOC122630237, transcript variant X1
uncharacterized LOC122630237, transcript variant X3
uncharacterized protein LOC122630237 isoform X1
uncharacterized protein LOC122630237 isoform X2
probable protein arginine N-methyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
DNA-directed RNA polymerases I, II, and III subunit RPABC1, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC1, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC1 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC1 isoform X2
growth factor receptor-bound protein 2, transcript variant X4
growth factor receptor-bound protein 2, transcript variant X6
growth factor receptor-bound protein 2, transcript variant X5
growth factor receptor-bound protein 2, transcript variant X3
growth factor receptor-bound protein 2, transcript variant X1
growth factor receptor-bound protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 2, transcript variant X3
regulating synaptic membrane exocytosis protein 2, transcript variant X5
regulating synaptic membrane exocytosis protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 2, transcript variant X1
regulating synaptic membrane exocytosis protein 2, transcript variant X2
regulating synaptic membrane exocytosis protein 2 isoform X3
regulating synaptic membrane exocytosis protein 2 isoform X2
regulating synaptic membrane exocytosis protein 2 isoform X5
regulating synaptic membrane exocytosis protein 2 isoform X4
regulating synaptic membrane exocytosis protein 2 isoform X1
regulating synaptic membrane exocytosis protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
regulating synaptic membrane exocytosis protein 2, transcript variant X6
regulating synaptic membrane exocytosis protein 2, transcript variant X8
regulating synaptic membrane exocytosis protein 1 isoform X8
regulating synaptic membrane exocytosis protein 1 isoform X7
regulating synaptic membrane exocytosis protein 1 isoform X6
cytochrome c oxidase assembly factor 3, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cytochrome c oxidase assembly factor 3, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
cytochrome c oxidase assembly factor 3, mitochondrial
mitochondrial dimethyladenosine transferase 1
intracellular protein transport protein USO1, transcript variant X2
intracellular protein transport protein USO1, transcript variant X1
intracellular protein transport protein USO1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 27-like
transcriptional activator Myb, transcript variant X6
transcriptional activator Myb, transcript variant X4
transcriptional activator Myb isoform X2
transcriptional activator Myb, transcript variant X5
transcriptional activator Myb, transcript variant X7
transcriptional activator Myb, transcript variant X1
transcriptional activator Myb, transcript variant X3
transcriptional activator Myb, transcript variant X2
transcriptional activator Myb isoform X1
transcriptional activator Myb isoform X3
RING finger and CHY zinc finger domain-containing protein 1
checkpoint protein HUS1, transcript variant X1
checkpoint protein HUS1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
UDP-glucuronosyltransferase 2B4-like, transcript variant X2
UDP-glucuronosyltransferase 2B4-like, transcript variant X5
UDP-glucuronosyltransferase 2B4-like, transcript variant X3
UDP-glucuronosyltransferase 2B4-like, transcript variant X4
UDP-glucuronosyltransferase 2B4-like, transcript variant X1
UDP-glucuronosyltransferase 2B4-like isoform X2
UDP-glucuronosyltransferase 2B4-like isoform X1
protein Wnt-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein Wnt-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X1
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X2
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X4
gamma-aminobutyric acid type B receptor subunit 2, transcript variant X3
gamma-aminobutyric acid type B receptor subunit 2 isoform X1
gamma-aminobutyric acid type B receptor subunit 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 241 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
5-aminolevulinate synthase, erythroid-specific, mitochondrial, transcript variant X2
5-aminolevulinate synthase, erythroid-specific, mitochondrial, transcript variant X1
5-aminolevulinate synthase, erythroid-specific, mitochondrial isoform X1
5-aminolevulinate synthase, erythroid-specific, mitochondrial isoform X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like
RNA-binding protein 5-like, transcript variant X1
RNA-binding protein 5-like, transcript variant X2
ELAV-like protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ELAV-like protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X2
ELAV-like protein 1, transcript variant X4
ELAV-like protein 1, transcript variant X3
ELAV-like protein 1, transcript variant X11
ELAV-like protein 1, transcript variant X1
ELAV-like protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ELAV-like protein 1, transcript variant X22
ELAV-like protein 1, transcript variant X23
eukaryotic translation initiation factor 2D, transcript variant X1
eukaryotic translation initiation factor 2D isoform X1
eukaryotic translation initiation factor 2D, transcript variant X2
eukaryotic translation initiation factor 2D isoform X2
PX domain-containing protein kinase-like protein, transcript variant X2
PX domain-containing protein kinase-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
PX domain-containing protein kinase-like protein isoform X1
PX domain-containing protein kinase-like protein isoform X2
protein prickle-like, transcript variant X4
protein prickle-like, transcript variant X5
protein prickle-like, transcript variant X3
protein prickle-like, transcript variant X7
protein prickle-like, transcript variant X6
protein prickle-like, transcript variant X1
protein prickle-like, transcript variant X2
uncharacterized LOC122630123, transcript variant X2
uncharacterized LOC122630123, transcript variant X1
uncharacterized LOC122630139, transcript variant X2
uncharacterized LOC122630139, transcript variant X1
transcriptional repressor p66-beta-like, transcript variant X9
transcriptional repressor p66-beta-like, transcript variant X1
transcriptional repressor p66-beta-like, transcript variant X2
transcriptional repressor p66-beta-like, transcript variant X4
transcriptional repressor p66-beta-like, transcript variant X10
transcriptional repressor p66-beta-like, transcript variant X3
transcriptional repressor p66-beta-like, transcript variant X6
transcriptional repressor p66-beta-like, transcript variant X5
transcriptional repressor p66-beta-like, transcript variant X7
transcriptional repressor p66-beta-like, transcript variant X8
transcriptional repressor p66-beta-like isoform X2
transcriptional repressor p66-beta-like isoform X5
transcriptional repressor p66-beta-like isoform X4
transcriptional repressor p66-beta-like isoform X1
transcriptional repressor p66-beta-like isoform X3
MAU2 chromatid cohesion factor homolog, transcript variant X2
MAU2 chromatid cohesion factor homolog, transcript variant X3
MAU2 chromatid cohesion factor homolog, transcript variant X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial-like
multiple C2 and transmembrane domain-containing protein, transcript variant X3
multiple C2 and transmembrane domain-containing protein, transcript variant X1
multiple C2 and transmembrane domain-containing protein, transcript variant X4
multiple C2 and transmembrane domain-containing protein, transcript variant X2
multiple C2 and transmembrane domain-containing protein, transcript variant X6
multiple C2 and transmembrane domain-containing protein, transcript variant X5
multiple C2 and transmembrane domain-containing protein, transcript variant X9
multiple C2 and transmembrane domain-containing protein, transcript variant X7
multiple C2 and transmembrane domain-containing protein isoform X3
multiple C2 and transmembrane domain-containing protein isoform X2
multiple C2 and transmembrane domain-containing protein isoform X1
multiple C2 and transmembrane domain-containing protein isoform X6
multiple C2 and transmembrane domain-containing protein isoform X4
multiple C2 and transmembrane domain-containing protein, transcript variant X8
multiple C2 and transmembrane domain-containing protein isoform X5
sprouty-related, EVH1 domain-containing protein 3, transcript variant X1
sprouty-related, EVH1 domain-containing protein 3, transcript variant X3
sprouty-related, EVH1 domain-containing protein 3, transcript variant X2
sprouty-related, EVH1 domain-containing protein 1 isoform X1
sprouty-related, EVH1 domain-containing protein 3 isoform X2
sprouty-related, EVH1 domain-containing protein 3, transcript variant X4
sprouty-related, EVH1 domain-containing protein 1 isoform X3
adrenodoxin-like protein 1, mitochondrial
general transcription factor IIH subunit 4, transcript variant X1
general transcription factor IIH subunit 4 isoform X1
general transcription factor IIH subunit 4, transcript variant X3
general transcription factor IIH subunit 4, transcript variant X2
general transcription factor IIH subunit 4 isoform X3
general transcription factor IIH subunit 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X1
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial, transcript variant X2
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial isoform X1
methylmalonic aciduria and homocystinuria type D homolog, mitochondrial isoform X2
AF4/FMR2 family member lilli-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
AF4/FMR2 family member lilli-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
AF4/FMR2 family member lilli-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
AF4/FMR2 family member lilli-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
AF4/FMR2 family member lilli-like, transcript variant X3
AF4/FMR2 family member lilli-like, transcript variant X1
AF4/FMR2 family member lilli-like isoform X2
uncharacterized protein LOC122630191 isoform X1
uncharacterized LOC122630193, transcript variant X5
uncharacterized LOC122630193, transcript variant X3
uncharacterized LOC122630193, transcript variant X2
uncharacterized LOC122630193, transcript variant X1
uncharacterized LOC122630193, transcript variant X4
uncharacterized protein LOC122630193 isoform X1
uncharacterized protein LOC122630193 isoform X2
uncharacterized protein LOC122630193 isoform X3
5'-3' exonuclease PLD3-like, transcript variant X1
5'-3' exonuclease PLD3-like, transcript variant X2
5'-3' exonuclease PLD3-like, transcript variant X4
5'-3' exonuclease PLD3-like, transcript variant X7
5'-3' exonuclease PLD3-like, transcript variant X8
5'-3' exonuclease PLD3-like, transcript variant X3
5'-3' exonuclease PLD3-like, transcript variant X5
5'-3' exonuclease PLD3-like, transcript variant X6
Fanconi anemia group M protein, transcript variant X2
Fanconi anemia group M protein, transcript variant X3
Fanconi anemia group M protein, transcript variant X4
Fanconi anemia group M protein isoform X2
Fanconi anemia group M protein, transcript variant X1
Fanconi anemia group M protein isoform X1
Fanconi anemia group M protein isoform X3
uncharacterized LOC122629802, transcript variant X2
uncharacterized LOC122629802, transcript variant X1
coiled-coil domain-containing protein 142
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122629978, transcript variant X3
uncharacterized LOC122629978, transcript variant X2
uncharacterized LOC122629978, transcript variant X1
uncharacterized LOC122629844, transcript variant X3
uncharacterized LOC122629844, transcript variant X2
uncharacterized LOC122629844, transcript variant X1
uncharacterized protein LOC122629844 isoform X2
uncharacterized protein LOC122629844 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122629758, transcript variant X1
uncharacterized LOC122629758, transcript variant X2
uncharacterized protein LOC122629758 isoform X1
uncharacterized protein LOC122629758 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
diacylglycerol lipase-beta-like, transcript variant X1
diacylglycerol lipase-beta-like, transcript variant X2
diacylglycerol lipase-beta-like, transcript variant X3
diacylglycerol lipase-beta-like isoform X1
diacylglycerol lipase-beta-like isoform X2
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
RNA polymerase I-specific transcription initiation factor RRN3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
RNA polymerase I-specific transcription initiation factor RRN3 isoform X1
RNA polymerase I-specific transcription initiation factor RRN3 isoform X2
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X1
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X1
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X3
ankyrin repeat and zinc finger domain-containing protein 1-like, transcript variant X2
ankyrin repeat and zinc finger domain-containing protein 1-like isoform X2
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X3
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X3
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X1
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial, transcript variant X2
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X1
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2-like isoform X3
uncharacterized LOC122629809, transcript variant X1
uncharacterized LOC122629809, transcript variant X2
adenosylhomocysteinase-like 1, transcript variant X2
adenosylhomocysteinase-like 1, transcript variant X4
adenosylhomocysteinase-like 1, transcript variant X1
adenosylhomocysteinase-like 1, transcript variant X6
adenosylhomocysteinase-like 1, transcript variant X3
adenosylhomocysteinase-like 1, transcript variant X5
adenosylhomocysteinase-like 1 isoform X5
adenosylhomocysteinase-like 1 isoform X3
adenosylhomocysteinase-like 1 isoform X2
adenosylhomocysteinase-like 1 isoform X1
adenosylhomocysteinase-like 1 isoform X4
rho GTPase-activating protein 190, transcript variant X1
rho GTPase-activating protein 190, transcript variant X5
rho GTPase-activating protein 190, transcript variant X4
rho GTPase-activating protein 190, transcript variant X3
rho GTPase-activating protein 190, transcript variant X2
rho GTPase-activating protein 190 isoform X1
rho GTPase-activating protein 190 isoform X3
rho GTPase-activating protein 190 isoform X2
potassium voltage-gated channel protein Shal, transcript variant X7
potassium voltage-gated channel protein Shal, transcript variant X8
potassium voltage-gated channel protein Shal, transcript variant X1
potassium voltage-gated channel protein Shal, transcript variant X2
potassium voltage-gated channel protein Shal, transcript variant X3
potassium voltage-gated channel protein Shal, transcript variant X4
potassium voltage-gated channel protein Shal, transcript variant X6
potassium voltage-gated channel protein Shal, transcript variant X5
potassium voltage-gated channel protein Shal isoform X2
potassium voltage-gated channel protein Shal isoform X1
potassium voltage-gated channel protein Shal isoform X3
potassium voltage-gated channel protein Shal isoform X4
potassium voltage-gated channel protein Shal isoform X5
glycine receptor subunit alpha-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glycine receptor subunit alpha-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glycine receptor subunit alpha-2-like, transcript variant X3
glycine receptor subunit alpha-2-like isoform X3
glycine receptor subunit alpha-4-like isoform X2
glycine receptor subunit alpha-4-like isoform X1
uncharacterized LOC122629874, transcript variant X2
uncharacterized LOC122629874, transcript variant X3
uncharacterized LOC122629874, transcript variant X1
uncharacterized LOC122629874, transcript variant X5
uncharacterized LOC122629874, transcript variant X6
uncharacterized protein LOC122629874 isoform X4
uncharacterized protein LOC122629874 isoform X3
uncharacterized protein LOC122629874 isoform X1
uncharacterized LOC122629874, transcript variant X4
uncharacterized protein LOC122629874 isoform X2
uncharacterized LOC122629874, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122629874, transcript variant X7
uncharacterized protein LOC122629874 isoform X5
uncharacterized LOC122629874, transcript variant X9
uncharacterized protein LOC122629874 isoform X6
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X2
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X3
phosphatidylinositol 3-kinase regulatory subunit alpha, transcript variant X1
phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2
uncharacterized protein LOC122629872 isoform X1
uncharacterized LOC122629878, transcript variant X2
uncharacterized LOC122629878, transcript variant X1
uncharacterized LOC122629877, transcript variant X1
uncharacterized LOC122629877, transcript variant X2
uncharacterized protein LOC122629877 isoform X1
uncharacterized protein LOC122629877 isoform X2
mitochondrial import inner membrane translocase subunit TIM50-C-like
uncharacterized LOC122630287, transcript variant X5
uncharacterized LOC122630287, transcript variant X4
uncharacterized LOC122630287, transcript variant X1
uncharacterized LOC122630287, transcript variant X3
uncharacterized LOC122630287, transcript variant X2
latrophilin Cirl-like, transcript variant X2
latrophilin Cirl-like, transcript variant X3
latrophilin Cirl-like, transcript variant X5
latrophilin Cirl-like, transcript variant X1
latrophilin Cirl-like, transcript variant X6
latrophilin Cirl-like, transcript variant X4
latrophilin Cirl-like, transcript variant X7
ankyrin repeat domain-containing protein 16-like, transcript variant X2
ankyrin repeat domain-containing protein 16-like, transcript variant X1
ankyrin repeat domain-containing protein 16-like isoform X2
ankyrin repeat domain-containing protein 16-like isoform X1
uncharacterized LOC122630283, transcript variant X5
uncharacterized LOC122630283, transcript variant X4
uncharacterized LOC122630283, transcript variant X3
uncharacterized LOC122630283, transcript variant X6
uncharacterized LOC122630283, transcript variant X2
uncharacterized LOC122630283, transcript variant X8
uncharacterized protein LOC122630283 isoform X2
uncharacterized protein LOC122630283 isoform X4
uncharacterized LOC122630283, transcript variant X1
uncharacterized LOC122630283, transcript variant X7
uncharacterized protein LOC122630283 isoform X1
uncharacterized protein LOC122630283 isoform X3
COMM domain-containing protein 10-like, transcript variant X2
COMM domain-containing protein 10-like isoform X2
COMM domain-containing protein 10-like, transcript variant X1
COMM domain-containing protein 10-like isoform X1
methylthioribulose-1-phosphate dehydratase, transcript variant X2
methylthioribulose-1-phosphate dehydratase isoform X2
methylthioribulose-1-phosphate dehydratase, transcript variant X1
CWF19-like protein 1, transcript variant X1
probable methylthioribulose-1-phosphate dehydratase isoform X1
CWF19-like protein 1, transcript variant X2
rho guanine nucleotide exchange factor 3-like, transcript variant X1
rho guanine nucleotide exchange factor 3-like isoform X1
rho guanine nucleotide exchange factor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
rho guanine nucleotide exchange factor 3-like isoform X2
N6-adenosine-methyltransferase subunit METTL3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
39S ribosomal protein L32, mitochondrial
protein spindle-F, transcript variant X1
protein spindle-F, transcript variant X2
signal recognition particle 54 kDa protein
myosin regulatory light chain LC-2, mantle muscle-like
uncharacterized LOC122630023, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC122630023 isoform X1
uncharacterized LOC122630023, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC122630023 isoform X2
choline-phosphate cytidylyltransferase A-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
ubiquinol-cytochrome-c reductase complex assembly factor 2
probable methyltransferase-like protein 15 homolog
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 388 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 388 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
C-1-tetrahydrofolate synthase, cytoplasmic, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 386 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
C-1-tetrahydrofolate synthase, cytoplasmic isoform X1
C-1-tetrahydrofolate synthase, cytoplasmic isoform X2
C-1-tetrahydrofolate synthase, cytoplasmic isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122629881, transcript variant X3
uncharacterized LOC122629881, transcript variant X4
uncharacterized LOC122629881, transcript variant X1
uncharacterized LOC122629881, transcript variant X2
uncharacterized LOC122629881, transcript variant X5
uncharacterized LOC122629928, transcript variant X3
uncharacterized LOC122629928, transcript variant X2
uncharacterized LOC122629928, transcript variant X1
AAC-rich mRNA clone AAC11 protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
AAC-rich mRNA clone AAC11 protein-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
AAC-rich mRNA clone AAC11 protein-like, transcript variant X4
AAC-rich mRNA clone AAC11 protein-like, transcript variant X2
AAC-rich mRNA clone AAC11 protein-like, transcript variant X8
AAC-rich mRNA clone AAC11 protein-like, transcript variant X3
AAC-rich mRNA clone AAC11 protein-like, transcript variant X1
nuclear transcription factor Y subunit gamma-like isoform X1
AAC-rich mRNA clone AAC11 protein-like, transcript variant X5
AAC-rich mRNA clone AAC11 protein-like isoform X2
homeobox protein prospero-like, transcript variant X3
homeobox protein prospero-like, transcript variant X1
homeobox protein prospero-like, transcript variant X2
homeobox protein prospero-like isoform X1
homeobox protein prospero-like isoform X2
homeobox protein prospero-like isoform X3
protein doublesex-like, transcript variant X5
protein doublesex-like, transcript variant X7
protein doublesex-like, transcript variant X6
protein doublesex-like, transcript variant X1
protein doublesex-like, transcript variant X4
protein doublesex-like, transcript variant X3
protein doublesex-like, transcript variant X2
protein doublesex-like, transcript variant X12
protein doublesex-like, transcript variant X8
protein doublesex-like, transcript variant X10
protein doublesex-like, transcript variant X11
protein doublesex-like, transcript variant X9
uncharacterized protein LOC122630182 isoform X1
uncharacterized protein LOC122630182 isoform X2
uncharacterized protein LOC122630182 isoform X3
cysteine sulfinic acid decarboxylase-like
uncharacterized LOC122629788, transcript variant X3
uncharacterized LOC122629788, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122629788, transcript variant X2
uncharacterized protein LOC122629788 isoform X2
uncharacterized protein LOC122629788 isoform X1
hemicentin-2-like, transcript variant X1
hemicentin-2-like, transcript variant X2
hemicentin-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 121 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
intracellular protein transport protein USO1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
26S proteasome non-ATPase regulatory subunit 9, transcript variant X1
26S proteasome non-ATPase regulatory subunit 9, transcript variant X2
26S proteasome non-ATPase regulatory subunit 9
tetratricopeptide repeat protein 30A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tetratricopeptide repeat protein 30A, transcript variant X1
tetratricopeptide repeat protein 30A, transcript variant X4
tetratricopeptide repeat protein 30A isoform X1
tetratricopeptide repeat protein 30A isoform X2
egl nine homolog 1, transcript variant X1
egl nine homolog 1, transcript variant X2
uncharacterized protein LOC122630101 isoform X2
dynein axonemal light chain 1-like, transcript variant X9
dynein axonemal light chain 1-like, transcript variant X3
dynein axonemal light chain 1-like, transcript variant X10
dynein axonemal light chain 1-like, transcript variant X2
dynein axonemal light chain 1-like, transcript variant X8
dynein axonemal light chain 1-like, transcript variant X6
dynein axonemal light chain 1-like, transcript variant X5
dynein axonemal light chain 1-like, transcript variant X7
dynein axonemal light chain 1-like, transcript variant X11
dynein axonemal light chain 1-like, transcript variant X4
dynein axonemal light chain 1-like, transcript variant X1
dynein axonemal light chain 1-like isoform X3
dynein axonemal light chain 1-like isoform X5
dynein axonemal light chain 1-like isoform X2
dynein axonemal light chain 1-like isoform X1
dynein axonemal light chain 1-like isoform X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X1
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X2
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X5
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X4
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X3
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like, transcript variant X6
serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform-like isoform X5
retinoblastoma-binding protein 5 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
retinoblastoma-binding protein 5 homolog, transcript variant X1
retinoblastoma-binding protein 5 homolog isoform X2
retinoblastoma-binding protein 5 homolog isoform X1
irregular chiasm C-roughest protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
irregular chiasm C-roughest protein-like isoform X1
irregular chiasm C-roughest protein-like isoform X2
irregular chiasm C-roughest protein-like isoform X3
irregular chiasm C-roughest protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
irregular chiasm C-roughest protein-like isoform X4
tyrosine-protein phosphatase 99A, transcript variant X3
tyrosine-protein phosphatase 99A, transcript variant X1
tyrosine-protein phosphatase 99A, transcript variant X2
tyrosine-protein phosphatase 99A isoform X3
tyrosine-protein phosphatase 99A isoform X1
tyrosine-protein phosphatase 99A isoform X2
tyrosine-protein phosphatase 99A, transcript variant X6
tyrosine-protein phosphatase 99A, transcript variant X4
tyrosine-protein phosphatase 99A, transcript variant X5
tyrosine-protein phosphatase 99A, transcript variant X7
tyrosine-protein phosphatase 99A isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
centrosomal protein of 120 kDa, transcript variant X1
centrosomal protein of 120 kDa, transcript variant X2
centrosomal protein of 120 kDa isoform X1
centrosomal protein of 120 kDa isoform X2
myogenesis-regulating glycosidase, transcript variant X2
myogenesis-regulating glycosidase, transcript variant X1
myogenesis-regulating glycosidase isoform X2
myogenesis-regulating glycosidase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
hippocampus abundant transcript 1 protein, transcript variant X3
hippocampus abundant transcript 1 protein, transcript variant X4
hippocampus abundant transcript 1 protein, transcript variant X2
hippocampus abundant transcript 1 protein, transcript variant X1
hippocampus abundant transcript 1 protein isoform X2
hippocampus abundant transcript 1 protein isoform X3
hippocampus abundant transcript 1 protein isoform X1
uncharacterized LOC122629900, transcript variant X7
uncharacterized LOC122629900, transcript variant X1
uncharacterized LOC122629900, transcript variant X3
uncharacterized LOC122629900, transcript variant X4
uncharacterized LOC122629900, transcript variant X2
uncharacterized LOC122629900, transcript variant X5
uncharacterized LOC122629900, transcript variant X6
uncharacterized LOC122629900, transcript variant X9
uncharacterized LOC122629900, transcript variant X8
uncharacterized LOC122629900, transcript variant X10
uncharacterized protein LOC122629900 isoform X1
uncharacterized protein LOC122629900 isoform X3
uncharacterized protein LOC122629900 isoform X2
uncharacterized protein LOC122629900 isoform X4
uncharacterized LOC122629900, transcript variant X11
uncharacterized protein LOC122629900 isoform X5
zinc finger protein 845-like, transcript variant X4
zinc finger protein 845-like, transcript variant X1
zinc finger protein 845-like, transcript variant X5
zinc finger protein 845-like, transcript variant X8
zinc finger protein 845-like, transcript variant X2
zinc finger protein 845-like, transcript variant X6
zinc finger protein 845-like, transcript variant X7
zinc finger protein 845-like, transcript variant X3
zinc finger protein 845-like, transcript variant X9
zinc finger protein 845-like, transcript variant X10
transcription initiation factor TFIID subunit 5, transcript variant X1
transcription initiation factor TFIID subunit 5, transcript variant X2
transcription initiation factor TFIID subunit 5 isoform X1
transcription initiation factor TFIID subunit 5 isoform X2
troponin C, isoallergen Bla g 6.0301, transcript variant X1
troponin C, isoallergen Bla g 6.0301, transcript variant X2
troponin C, isoallergen Bla g 6.0301 isoform X2
troponin C, isoallergen Bla g 6.0301 isoform X1
translocon-associated protein subunit gamma
uncharacterized LOC122629901, transcript variant X5
uncharacterized LOC122629901, transcript variant X6
uncharacterized LOC122629901, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122629901, transcript variant X3
uncharacterized LOC122629901, transcript variant X2
uncharacterized LOC122629901, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122629901, transcript variant X1
uncharacterized LOC122629901, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC122629901, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC122629901, transcript variant X8
uncharacterized LOC122629901, transcript variant X9
uncharacterized protein LOC122629901 isoform X6
uncharacterized protein LOC122629901 isoform X2
uncharacterized protein LOC122629901 isoform X1
uncharacterized protein LOC122629901 isoform X5
uncharacterized protein LOC122629901 isoform X3
uncharacterized protein LOC122629901 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein spaetzle 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein spaetzle 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein spaetzle 3, transcript variant X4
protein spaetzle 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
CD151 antigen-like, transcript variant X1
CD151 antigen-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tropomyosin-1, isoforms 33/34 isoform X13
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122629778, transcript variant X2
uncharacterized LOC122629778, transcript variant X3
uncharacterized LOC122629778, transcript variant X1
uncharacterized protein LOC122629778 isoform X1
uncharacterized protein LOC122629778 isoform X2
uncharacterized LOC122629964, transcript variant X2
uncharacterized LOC122629964, transcript variant X1
E3 ubiquitin-protein ligase RNF146, transcript variant X2
E3 ubiquitin-protein ligase RNF146, transcript variant X1
E3 ubiquitin-protein ligase RNF146 isoform X1
E3 ubiquitin-protein ligase RNF146 isoform X2
maternal protein tudor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
maternal protein tudor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
beta-1,3-galactosyltransferase brn, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
beta-1,3-galactosyltransferase brn, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X1
Sjoegren syndrome nuclear autoantigen 1 homolog, transcript variant X2
Sjoegren syndrome nuclear autoantigen 1 homolog
ATP-dependent Clp protease proteolytic subunit
protein limb expression 1 homolog, transcript variant X2
protein limb expression 1 homolog, transcript variant X1
putative uncharacterized protein DDB_G0282133
uncharacterized LOC122630247, transcript variant X2
uncharacterized LOC122630247, transcript variant X1
uncharacterized protein LOC122630247 isoform X1
uncharacterized protein LOC122630247 isoform X2
ATP-binding cassette sub-family A member 2-like, transcript variant X2
ATP-binding cassette sub-family A member 2-like, transcript variant X4
ATP-binding cassette sub-family A member 2-like, transcript variant X3
ATP-binding cassette sub-family A member 2-like, transcript variant X1
ATP-binding cassette sub-family A member 2-like isoform X2
ATP-binding cassette sub-family A member 2-like isoform X1
pupal cuticle protein 20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pupal cuticle protein 20-like, transcript variant X1
pupal cuticle protein 20-like isoform X2
pupal cuticle protein 20-like isoform X1
uncharacterized LOC122630115, transcript variant X1
uncharacterized protein LOC122630115 isoform X1
uncharacterized LOC122630115, transcript variant X2
uncharacterized protein LOC122630115 isoform X2
heterogeneous nuclear ribonucleoprotein K-like
cytochrome b5-like, transcript variant X1
cytochrome b5-like, transcript variant X2